A valuable weapon in war against drug-resistant superbugs: Antibiotic offers hope
Tests show that drug is effective against the same kind of chronic bacterial infections that have killed hospital patients
Steve Connor is the Science Editor of The Independent. He has won many awards for his journalism, including five-times winner of the prestigious British science writers’ award; the David Perlman Award of the American Geophysical Union; twice commended as specialist journalist of the year in the UK Press Awards; UK health journalist of the year and a special merit award of the European School of Oncology for his investigative journalism. He has a degree in zoology from the University of Oxford and has a special interest in genetics and medical science, human evolution and origins, climate change and the environment.
Wednesday 13 November 2013
A new kind of antibiotic that causes microbes to digest themselves has been developed by scientists who believe it could become a valuable weapon in the war against drug-resistant “superbugs”.
Laboratory tests show that the drug is effective against persistent strains of the Staphylococcus bacterium and is able to cure laboratory mice of the same kind of chronic bacterial infections that have killed hospital patients.
Kim Lewis of Northeastern University in Boston, Massachusetts, said that the drug, called acyldepsipeptide (ADEP4), works by activating an enzyme within the dormant “persister” cells of the bacteria, which causes these hardened microbial cells to self-digest.
“Persister cells don’t grow. They shut down their metabolism and in order for antibiotics to work against bacteria, the microbes must grow. ADEP4 essentially forces the cells to self-digest. The compound has an ability to sterilise an infection,” Dr Lewis said.
ADEP4 activates a protease enzyme that breaks down proteins within bacteria. However, resistance soon develops against the drug, which is why it was abandoned by the drug industry in the 1980s as a possible antibiotic, he said.
The study, published in the journal Nature, demonstrated however that when ADEP4 is used in conjunction with a conventional antibiotic, such as rifampicin, it is very effective at ridding an infection of the persister cells that are often left untouched by the treatment.
“They become susceptible to killing by any antibiotic essentially. One of the major causes of drug resistance is a large, lingering population of pathogens which happens in patients with chronic infections,” Dr Lewis said.
“If you can rapidly sterilise and get rid of that large population, you then get rid of an enormous source of resistance acquisition,” he said.
Kenn Gerdes of Newcastle University and Hanne Ingmer of the University of Copenhagen said in an accompanying article in Nature that the results were “remarkable” and offer hope for a new way of tackling resistant bacterial infections.
“This growing body of results generates hope that antibiotics for the treatment of persistent infections will be available in the future,” they say.
- 1 Home Office says Nigerian asylum-seeker can’t be a lesbian as she’s got children
- 2 What happens to your body when you give up sugar?
- 3 Drugs Live cannabis trial: Hash is less harmful than any other drug, expert claims
- 4 Turkish Airlines flight TK 726 crash-lands on Nepal runway amid dense fog
- 5 Apple and Google users being spied on for a decade because of 'Freak' security flaw
The City of the Monkey God: Archaeologists claim to have found city lost for 1,000 years in remote Honduran jungle
Turkish Airlines flight TK 726 crash-lands on Nepal runway amid dense fog
Japanese island overrun with cats after population explodes
London property boom built on dirty money
Becky Watts: Stepbrother and his girlfriend named locally as two arrested on suspicion of murder
'Jihadi John': CAGE representative storms off Sky News accusing Kay Burley of Islamophobia
Durham Free School: 'Creationism taught at' free school facing closure
Nearly 100,000 of Britain's poorest children go hungry after parents' benefits are cut
Ukip would cut billions from Scottish budget to fund English tax cuts
End of the licence fee: BBC to back radical overhaul of how it is funded
Ukraine crisis: Top Chinese diplomat backs Putin and says West should 'abandon zero-sum mentality'
£18000 - £22000 per annum: Recruitment Genius: A great opportunity has arisen ...
£14000 - £16000 per annum: Recruitment Genius: Full time and Part time positio...
£45000 per annum: Ashdown Group: An established and reputable Not for Profit o...
£14000 - £17000 per annum: Recruitment Genius: A Sales Ledger & Credit Control...